Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > LABS, Pfizer, Technion University..and don't forget, Bourla
View:
Post by subaru1i on Feb 02, 2024 9:51am

LABS, Pfizer, Technion University..and don't forget, Bourla

of Pfizer received the honorary Phd degree from Technion as well as the ground breaking work conducted by Dedi Meri on which cannabinoid compounds worked most effectively as a combination against different types of cancers.   Cancer rates increasing by 75% upon the global population, it's easy to make money when you understand imperfection and a Planet π dying.   We get evicted first.   

Technion scientists predict the efficacy of novel therapies in cancer

Story by BY JUDY SIEGEL-ITZKOVICH • 6h
Comment by unplugged1 on Feb 02, 2024 10:10am
pfizer will cease to exist within 3yrs for crimes against humanity imo you live in a cave?
Comment by subaru1i on Feb 02, 2024 10:16am
I don't live in a cave, Athea is of quantum flesh, she is like a big fluffy cloud of quantum particles, so you can call me a 'bubble boy' but not a cave man.  
Comment by subaru1i on Feb 02, 2024 10:18am
Crimes against humanity?  When you go fishing, always set your sights on the biggest fish.   Read your history of the U.S. frying innocent women and children to test their new nuclear toy and holding back discoveries in science from other people so that they can put those discoveries in use as weapons.    Do you know what you live within?  
Comment by subaru1 on Feb 02, 2024 10:59am
Subaru1i you are out of control this morning relax a bit.
Comment by Starkicker on Feb 02, 2024 11:49am
Haven't checked in here for a few months and didn't think the LABS forum could get any goofier but I was wrong! Y'all are wasting your time with this one! S1i.... gonna jump to $4/share?....lolololol. C'mon man, you're killing me!!!...LMAO. Invest in real companies that make real money, otherwise you're just gambling and losing.
Comment by subaru1i on Feb 02, 2024 1:03pm
star"kicker"...on ignore as well.   I don't have time for you clowns. 
Comment by unplugged1 on Feb 02, 2024 11:07am
it is you that needs education.  I know you like to think you own this board just have to be the last post every day, and the first post every morning and all day long but really, you should emerge from this little bubble you live in., there's a whole world out there outside stockhouse forum. The proof is everywhere except MSM.  Pfizer are going to lose their immunity for the covid ...more  
Comment by subaru1i on Feb 02, 2024 1:01pm
unplugged...an appropriate name.  You're on ignore also.  Have a wonderful Life π.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities